2016
DOI: 10.1183/13993003.00401-2016
|View full text |Cite
|
Sign up to set email alerts
|

Adding biological markers to COPD categorisation schemes: a way towards more personalised care?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 46 publications
(37 reference statements)
0
4
0
Order By: Relevance
“…Chronic obstructive pulmonary disease (COPD) is a chronic health problem with high morbidity and mortality 1,2 . The Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) defines it as a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases 3 It is a complex heterogenous condition that has also been described as a syndrome 4 . Its etiology is multifactorial with smoking remaining the primary cause.…”
Section: Introductionmentioning
confidence: 99%
“…Chronic obstructive pulmonary disease (COPD) is a chronic health problem with high morbidity and mortality 1,2 . The Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) defines it as a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases 3 It is a complex heterogenous condition that has also been described as a syndrome 4 . Its etiology is multifactorial with smoking remaining the primary cause.…”
Section: Introductionmentioning
confidence: 99%
“…COPD phenotypes is essential to provide patients with precise and personalized therapy. Most phenotypes rely on clinical and physiological parameters and biological markers may complete them, clinicians should select the tools to be used according to the aim of phenotyping such as prognosis evaluation , treatmet response or research (Roche, 2016). Some research studies have examined specific phenotype frequencies and features but limited ones are available to address the effect of these phenotypes on clinical outcome, purposing to intensify the lines of treatment available for those with the worst outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…In clinical practice, however, it is important to define and manage the determinant factors of therapeutic success in COPD. There is a need to personalise treatment strategies,11 and four goals must be achieved. First, we have to assess the patient in a multidimensional way, according to the severity of the disease, its activity, future risk and impact on the patient, including their well-being.…”
mentioning
confidence: 99%